Merrimack Pharmaceuticals Stock (NASDAQ:MACK)
Previous Close
$15.13
52W Range
$11.53 - $15.89
50D Avg
$14.80
200D Avg
$13.36
Market Cap
$223.97M
Avg Vol (3M)
$182.63K
Beta
1.42
Div Yield
$15.10 (99.70%)
MACK Company Profile
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.